Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern Time

Rhea-AI Summary

Senseonics Holdings, Inc. (SENS) plans to release its first quarter 2022 financial results after market close on May 10, 2022. A conference call to discuss its performance will start at 4:30 p.m. ET on the same day, accessible via a dedicated webcast on their website. Senseonics focuses on developing long-term, implantable continuous glucose monitoring (CGM) systems for diabetes management, with products like Eversense® and Eversense® E3, which automatically send glucose data to smartphones every 5 minutes.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2022 financial results after market close on Tuesday, May 10, 2022.

Management will hold a conference call to review the Company’s first quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 9027379, approximately ten to five minutes prior to start time.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220426006209/en/

Senseonics Investor Contact

Philip Taylor

Investor Relations

415-937-5406

investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

When will Senseonics release its Q1 2022 financial results?

Senseonics will release its Q1 2022 financial results after market close on May 10, 2022.

What time is the Senseonics conference call for Q1 2022?

The Senseonics conference call to discuss Q1 2022 results will start at 4:30 p.m. ET on May 10, 2022.

How can I access the Senseonics Q1 2022 conference call?

You can access the Senseonics Q1 2022 conference call via a webcast on their website.

What products does Senseonics offer for glucose monitoring?

Senseonics offers long-term implantable CGM systems including Eversense®, Eversense® XL, and Eversense® E3.